Isolation of antibodies to hypochlorite-modified low-density lipoproteins from human serum and study of their specificity.



Cite item

Full Text

Abstract

BACKGROUND: Modified low-density lipoproteins (LDL) have immunogenic properties and induce the production of antibodies. In this case, HOCl promotes the formation of subsequent active halogen-containing compounds interacting with proteins and lipid parts of LDL, which leads to their modification and the production of antibodies to them. The aim of this work is to isolate antibodies to hypochlorite-LDL from human blood sera and study their specificity.

MATERIALS AND METHODS: Malondialdehyde (MDA-LDL), acetic anhydride (acet-LDL) and sodium hypochlorite (hypochlorite-LDL) were used to obtain modified LDL. IgG antibodies to hypochlorite-LDL were isolated by affinity chromatography. The total IgG fraction antibodies was previously isolated from human blood sera using MabSelect Xtra. The specific antibodies to hypochlorite-LDL were isolated from this IgG pool by affinity chromatography. CNBr-Sepharose 4B conjugated with human serum albumin modified with NaOCl was used as a sorbent. The specificity of antibodies against hypochlorite-LDL was tested using a competitive enzyme-linked immunosorbent assay (ELISA). The competitors were hypochlorite-LDL, acet-LDL and MDA-LDL in concentrations (1-250 μg/ml).

RESULTS: IgG antibodies against hypochlorite-modified proteins that interact with hypochlorite-LDL were detected in human blood. According to ELISA date the binding of the isolated antibodies to hypochlorite-LDL was almost completely inhibited only by appropriately modified LDL, that is, hypochlorite-LDL, but not native LDL or acet-LDL. MDA-LDL also showed some competitive activity, but much weaker than hypochlorite-LDL. Hypochlorite-LDL itself and, to a lesser extent, MDA-LDL competed for binding with antibodies of human serum to hypochlorite-LDL. Acet-LDL and native LDL did not reduce the efficiency of antibody binding to their antigen.

CONCLUSIONS: Hypochlorite-LDL forms epitopes independent of other LDL modifications studied. These epitopes are responsible for the formation of specific antibodies.

About the authors

Ksenia N. Grigoreva

Peter the Great St.Petersburg Polytechnic University; Federal State Budgetary Scientific Institution ‘Institute of Experimental Medicine’

Email: ks_grigorieva24@mail.ru
ORCID iD: 0009-0005-3818-9835

student

Russian Federation, 195251, St.Petersburg, Polytechnicheskaya, 29 B; 197022, Saint-Petersburg, 12, Acad. Pavlov Street

Alexandra A. Dmitrieva

Federal State Budgetary Scientific Institution ‘Institute of Experimental Medicine’

Email: aleksandra-2001@mail.ru
ORCID iD: 0000-0003-2680-4069
SPIN-code: 3009-2698

junior research assistant Department of Biochemistry

Russian Federation, 197022, Saint-Petersburg, 12, Acad. Pavlov Street

Anna A. Ivanova

Federal State Budgetary Scientific Institution ‘Institute of Experimental Medicine’

Author for correspondence.
Email: anna.ivantcova@gmail.com
ORCID iD: 0000-0002-8673-9628
SPIN-code: 5306-1995

research assistant Department of Biochemistry

Russian Federation, 197022, Saint-Petersburg, 12, Acad. Pavlov Street

Aleksandr D. Denisenko

Institute of Experimental Medicine

Email: add@iem.sp.ru
ORCID iD: 0000-0003-1613-0654
SPIN-code: 7496-1449

Doctor of Medicine Science, professor, Head
of the Laboratory of Regulation of Lipid Metabolism

Russian Federation, 197022, Saint-Petersburg, 12, Acad. Pavlov Street

References

  1. Denisenko A. D. Autoimmune lipoprotein-antibody complexes and their role in atherogenesis. Meditsinskij Akademitsjeskij Journal. 2007;7(1):38-44.
  2. Pigarevsky PV, Archipova OYu, Denisenko AD. Detection of modified lipoproteins in atherosclerotic lesions of human aorta. Medical Immunology (Russia), 2006;8(5-6):637-644. (In Russ.) doi.org/10.15789/1563-0625-2006-5-6-637-644
  3. Belik I. V., Ivantsova A. A., Mamedova Z. E., et. al. Antibodies against modified low-density lipoproteins and their complexes in blood of patients with various manifestations of atherosclerosis. Biochemistry Suppl. Ser. B: Biomed. Chem. 2016;10(4):346-350. doi: 10.1134/S1990750816040028
  4. Denisenko A.D. Vinogradov A.G., Dizhe E.B., Sukonina V.E. Antilipoprotein autoantibodies (Aab), lipoprotein-antibody immune complexes (Lp-Ab IV) and atherosclerosis. In: Advances in Lipoprotein and Atherosclerosis Research, Diagnostics and Treatment. Proceedings of the 10th International Dresden Lipid Symposium. Eds. W. Jaross, M. Hanefeld, S. Bergmann, M. Menschikovski, Dresden. 1999;75-79.
  5. Malle E, Waeg G, Schreiber R, et. al. Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins. Eur J Biochem. 2000;267(14):4495-503. doi: 10.1046/j.1432-1327.2000.01498.x.
  6. Schindhelm RK, van der Zwan LP, Teerlink T, et. al. Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification? Clin Chem. 2009;55(8):1462-70. doi: 10.1373/clinchem.2009.126029.
  7. Sokolov AV, Kostevich VA, Runova OL, et. al. Proatherogenic modification of LDL by surface-bound myeloperoxidase. Chem Phys Lipids. 2014;180:72-80. doi: 10.1016/j.chemphyslip.2014.02.006.
  8. Hazell LJ, van den Berg JJ, Stocker R. Oxidation of low-density lipoprotein by hypochlorite causes aggregation that is mediated by modification of lysine residues rather than lipid oxidation. Biochem J. 1994;302(Pt 1):297-304. doi: 10.1042/bj3020297.
  9. Kopprasch S, Leonhardt W, Pietzsch J, et. al. Hypochlorite-modified low-density lipoprotein stimulates human polymorphonuclear leukocytes for enhanced production of reactive oxygen metabolites, enzyme secretion, and adhesion to endothelial cells. Atherosclerosis. 1998;136(2):315-24. doi: 10.1016/s0021-9150(97)00233-5
  10. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955;34(9):1345-53. doi: 10.1172/JCI103182.
  11. Markwell MA, Haas SM, Bieber LL, et. al. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem. 1978;87(1):206-10. doi: 10.1016/0003-2697(78)90586-9.
  12. Palinski W, Ylä-Herttuala S, Rosenfeld ME, et. al. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis. 1990;10(3):325-35. doi: 10.1161/01.atv.10.3.325.
  13. Fields R. The rapid determination of amino groups with TNBS. Methods Enzymol. 1972;25:464-468. doi: 10.1016/S0076-6879(72)25042-X.
  14. Smith PK, Krohn RI, Hermanson GT,et. al. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985;150(1):76-85. doi: 10.1016/0003-2697(85)90442-7.
  15. Hawkins CL, Pattison DI, Davies MJ. Hypochlorite-induced oxidation of amino acids, peptides and proteins. Amino Acids. 2003;25(3-4):259-74. doi: 10.1007/s00726-003-0016-x.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) Eco-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 74760 от 29.12.2018 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies